View our free, on-demand webinar series to learn about the Genexus System and FusionSync technology

Part 1: Introducing a New World of NGS: A One-Day, Hands-Off Solution to Fit in any Lab

  • How the new Ion Torrent Genexus System is addressing key challenges to next-generation sequencing (NGS) implementation, like hands-on time, time-to-result, user expertise, and affordability
  • Why, in combination with the new Oncomine Precision Assay, the Genexus System represents a new-generation solution for genomic profiling of cancer samples
  • Thoughts from the first-ever laboratory to implement this solution: IPATIMUB in Portugal

Speakers:

José Luis Costa, PhD
Principal Researcher, IPATIMUP
Andy Felton, PhD
Vice President of Marketing and Product Management, Clinical Next Generation Sequencing, Thermo Fisher Scientific

Part 2: A New World of NGS. A New Day for Your Lab.

  • Understand how the new Genexus System enables a broad spectrum of labs, even without previous expertise, to provide fast genomic profiling
  • See the future Genexus System assays pipeline
  • Hear from Sentara Molecular Pathology Laboratory about their experience with the Genexus System

Speakers:

Tabetha Sundin
Scientific Director, Molecular Diagnostics and Serology, Sentara Healthcare, Norfolk, Virginia
Andy Felton, PhD
Vice President of Marketing and Product Management, Clinical Next Generation Sequencing, Thermo Fisher Scientific
Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Part 3: Hear Both Sides of the Fusion Detection Story

  • Discuss the importance of detecting both novel fusions and known driver genes and partners
  • Review three different methods of fusion detection in a comparison study performed and presented by Dr. Wei Song
  • Hear about principle data generated by a new FusionSync method by Dr. Philip Jermann

Speakers:

Dr. Wei Song, MD, PhD
Director of the Clinical Genomic Laboratory, Englander Institute for Precision Medicine
Assistant Professor of Pathology and Laboratory Medicine, Weill Cornell Medical College
Assistant Attending Pathologist, NewYork-Presbyterian Hospital
Dr. Philip Jermann, PhD
Head of Molecular Assay Development Unit Institute of Medical Genetics and Pathology, University Hospital Basel, Switzerland


Fill in the form to view the free on-demand webinar.

(*Indicates a mandatory field)